Is Total Arterial Revascularization Superior to Multiarterial Grafting in Coronary Artery Bypass Grafting

Retrospective study of adult patients with multivessel disease undergoing isolated coronary artery bypass grafting (CABG) in three centers between January 1st, 2009, and December 31st, 2023. Patients were grouped according to the revascularization strategy (total arterial revascularization vs. multiarterial grafting). Primary outcome was a composite of major adverse cardiac and cerebrovascular events (MACCE).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

CABG Revascularization

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

isolated CABG

Exclusion criteria

single vessel CABG
CABG with utilization of only one arterial graft

Treatment and study plan

CABG

Procedure

All patients underwent isolated CABG and retrospectively followed to asses clinical outcomes of the two different revascularization techniques

Primary outcomes

MACCE

Time frame: through study completion, a median of 101 months

Secondary outcomes

Mortality

Time frame: through study completion, a median of 101 months
MI

Time frame: through study completion, a median of 101 months
CVA

Time frame: through study completion, a median of 101 months
repeat revascularization

Time frame: through study completion, a median of 101 months

Sponsors and collaborators

Lead sponsor

Technion, Israel Institute of Technology

Other

Registry information

Important dates

Study start: 2009
Primary completion: 2023
Study completion: 2023
First posted: Jan 9, 2025
Registry last updated: Jan 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting